Your post is nothing but a speculative announcement - take it to the Pro-Vaxx forum and see if it fits there.  It is a non issue here. 

Or do you somehow want to debate a rodent study for a vaccine that is made up of modified cold and pox viruses that has not entered safety tests in humans yet?

When and if it is approved, then we can take a look at issues like the ingredients it contains, any side effects they might admit to, and the major sources of funding for the study.

I note that the Jenner Institute division of Oxford College, which most of the researchers are associated with, derives much of it's funding from industry sources.

I also note the connection of one researcher to Imaxio, which is a vaccine manufacturer formerly known as Avidis.  And one can scarcely dismiss the other listed connections as non industry related.  After all, Imaxio itself was founded in 2000 as a spin-off from the Medical Research Council, UK and Cambridge University, UK and has acquired the French company Diagnogene in 2006.

DQ